These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 28892416)

  • 1. Roman high and low avoidance rats differ in their response to chronic olanzapine treatment at the level of body weight regulation, glucose homeostasis, and cortico-mesolimbic gene expression.
    Evers SS; Boersma GJ; Tamashiro KL; Scheurink AJ; van Dijk G
    J Psychopharmacol; 2017 Nov; 31(11):1437-1452. PubMed ID: 28892416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hormonal and metabolic effects of olanzapine and clozapine related to body weight in rodents.
    Albaugh VL; Henry CR; Bello NT; Hajnal A; Lynch SL; Halle B; Lynch CJ
    Obesity (Silver Spring); 2006 Jan; 14(1):36-51. PubMed ID: 16493121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential activation of dopamine release in the nucleus accumbens core and shell after acute or repeated amphetamine injections: a comparative study in the Roman high- and low-avoidance rat lines.
    Giorgi O; Piras G; Lecca D; Corda MG
    Neuroscience; 2005; 135(3):987-98. PubMed ID: 16154292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Olanzapine effects on body composition, food preference, glucose metabolism and insulin sensitivity in the rat.
    Smith GC; Vickers MH; Shepherd PR
    Arch Physiol Biochem; 2011 Oct; 117(4):241-9. PubMed ID: 21671852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of olanzapine and betahistine co-treatment on serotonin transporter, 5-HT2A and dopamine D2 receptor binding density.
    Lian J; Huang XF; Pai N; Deng C
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Dec; 47():62-8. PubMed ID: 23994047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early antipsychotic exposure affects serotonin and dopamine receptor binding density differently in selected brain loci of male and female juvenile rats.
    Lian J; Pan B; Deng C
    Pharmacol Rep; 2016 Oct; 68(5):1028-35. PubMed ID: 27428765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GABAergic and dopaminergic transmission in the brain of Roman high-avoidance and Roman low-avoidance rats.
    Giorgi O; Orlandi M; Escorihuela RM; Driscoll P; Lecca D; Corda MG
    Brain Res; 1994 Feb; 638(1-2):133-8. PubMed ID: 8199854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic betahistine co-treatment reverses olanzapine's effects on dopamine D₂ but not 5-HT2A/2C bindings in rat brains.
    Lian J; Huang XF; Pai N; Deng C
    Prog Neuropsychopharmacol Biol Psychiatry; 2015 Jan; 56():75-80. PubMed ID: 25149912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced efficacy of both typical and atypical antipsychotic drugs by adjunctive alpha2 adrenoceptor blockade: experimental evidence.
    Wadenberg ML; Wiker C; Svensson TH
    Int J Neuropsychopharmacol; 2007 Apr; 10(2):191-202. PubMed ID: 16707032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preclinical pharmacology of FMPD [6-fluoro-10-[3-(2-methoxyethyl)-4-methyl-piperazin-1-yl]-2-methyl-4H-3-thia-4,9-diaza-benzo[f]azulene]: a potential novel antipsychotic with lower histamine H1 receptor affinity than olanzapine.
    Rasmussen K; Benvenga MJ; Bymaster FP; Calligaro DO; Cohen IR; Falcone JF; Hemrick-Luecke SK; Martin FM; Moore NA; Nisenbaum LK; Schaus JM; Sundquist SJ; Tupper DE; Wiernicki TR; Nelson DL
    J Pharmacol Exp Ther; 2005 Dec; 315(3):1265-77. PubMed ID: 16141369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Olanzapine, not resperidone, exacerbates beta-cell function and mass in ovariectomized diabetic rats and estrogen replacement reverses them.
    Park S; Sang Mee Hong ; Il Sung Ahn ; Sung Hoon Kim
    J Psychopharmacol; 2010 Jul; 24(7):1105-14. PubMed ID: 19965940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of olanzapine on body composition and energy expenditure in adults with first-episode psychosis.
    Graham KA; Perkins DO; Edwards LJ; Barrier RC; Lieberman JA; Harp JB
    Am J Psychiatry; 2005 Jan; 162(1):118-23. PubMed ID: 15625209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aripiprazole differentially affects mesolimbic and nigrostriatal dopaminergic transmission: implications for long-term drug efficacy and low extrapyramidal side-effects.
    Han M; Huang XF; Deng C
    Int J Neuropsychopharmacol; 2009 Aug; 12(7):941-52. PubMed ID: 19203411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Divergent anatomical pattern of D1 and D3 binding and dopamine- and cyclic AMP-regulated phosphoprotein of 32 kDa mRNA expression in the Roman rat strains: Implications for drug addiction.
    Guitart-Masip M; Johansson B; Fernández-Teruel A; Cañete T; Tobeña A; Terenius L; Giménez-Llort L
    Neuroscience; 2006 Nov; 142(4):1231-43. PubMed ID: 17008016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Orally disintegrating and oral standard olanzapine tablets similarly elevate the homeostasis model assessment of insulin resistance index and plasma triglyceride levels in 12 healthy men: a randomized crossover study.
    Vidarsdottir S; Vlug P; Roelfsema F; Frölich M; Pijl H
    J Clin Psychiatry; 2010 Sep; 71(9):1205-11. PubMed ID: 20441717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prefrontal cortical D1 dopamine receptors modulate subcortical D2 dopamine receptor-mediated stress responsiveness.
    Scornaiencki R; Cantrup R; Rushlow WJ; Rajakumar N
    Int J Neuropsychopharmacol; 2009 Oct; 12(9):1195-208. PubMed ID: 19275776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of the adverse effects of olanzapine on lipid metabolism with the antiepileptic zonisamide.
    Stefanidis A; Watt MJ; Cowley MA; Oldfield BJ
    Neuropharmacology; 2017 Sep; 123():55-66. PubMed ID: 28400260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Olanzapine: a basic science update.
    Bymaster F; Perry KW; Nelson DL; Wong DT; Rasmussen K; Moore NA; Calligaro DO
    Br J Psychiatry Suppl; 1999; (37):36-40. PubMed ID: 10211140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of olanzapine on muscarinic M3 receptor binding density in the brain relates to weight gain, plasma insulin and metabolic hormone levels.
    Weston-Green K; Huang XF; Lian J; Deng C
    Eur Neuropsychopharmacol; 2012 May; 22(5):364-73. PubMed ID: 21982116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of 5-HT2A receptors in prefrontal cortex pyramidal neurons projecting to nucleus accumbens. Potential relevance for atypical antipsychotic action.
    Mocci G; Jiménez-Sánchez L; Adell A; Cortés R; Artigas F
    Neuropharmacology; 2014 Apr; 79():49-58. PubMed ID: 24211653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.